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a b s t r a c t
Multimodality imaging in coronary artery disease (CAD) comprises a combination of infor-
mation from more than one imaging technique. These combinations, performed in a side-
by-side or fusion mode, include computed tomography (CT) and single photon emission
computed tomography (SPECT), positron emission tomography (PET) and CT, and PET with
magnetic resonance imaging (MRI). Data thus obtained lead to either a summative or
synergistic gain of information. For instance, morphology (coronary plaques/stenosis)
can be depicted by coronary CT angiography, whereas functional aspects of CAD such as
myocardial perfusion abnormalities or myocardial metabolism can be evaluated by the
complementary technique in order to separate a hemodynamic signiﬁcant coronary steno-
sis from a hemodynamic non-signiﬁcant stenosis. Distinguishing these two entities has an
important impact on patient management. Beyond the diagnostic yield, some of these
combinations in multimodality imaging also have prognostic implications. In this article, we
will describe different multimodality imaging approaches (CT/SPECT, PET/CT and PET/MRI)
for evaluation of CAD in patients with suspected or known CAD and put them into the
context of current knowledge.
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Strictly deﬁned multimodality (hybrid) cardiovascular imaging
comprises a combination of a least two out of the four
following cardiovascular imaging techniques: CT, SPECT, PET,
and MRI. More general, multimodality cardiovascular imaging
is frequently used for any combination of imaging techniques
employed to study the diagnosis or functional implications of
cardiovascular disease. In this article, we will focus on
multimodality cardiovascular imaging using the stricter
deﬁnition.
Non-invasive methods of cardiac imaging have developed
rapidly during the last 10 years [1]. This is most obvious in the
ﬁeld of suspected or known coronary artery disease, where
non-invasive imaging techniques are employed for the
evaluation of diagnosis, prognosis and risk stratiﬁcation.
Besides morphology of the coronary vessels, functional
alterations on myocardial perfusion and metabolism due to
coronary stenosis are of high clinical interest, since only
patients with both anatomically and functionally relevant
stenosis beneﬁt from revascularization [2]. The primary aim of
a multimodality imaging approach should be providing
synergistic rather than summative diagnostic and prognostic
information, guiding the clinician in his further treatment
options. By the use of multimodality imaging, the clinician
should be capable of dividing patients with suspected or
known CAD in a conservative, optimal medical therapy group
vs. a group who might beneﬁt with reasonable probability from
interventional therapies. Despite all improvements and
reﬁnements in non-invasive imaging, a patient-tailored
approach, which is additionally based on clinical judgment,
remains mandatory to ﬁnd the best practice for the individual
patient. This article summarizes commonly used imaging
techniques (except echocardiography) and their combinations
for the non-invasive evaluation of patients with suspected or
known CAD.
Commonly used combinations of cardiac imaging
modalities
CT/SPECT
Coronary artery calcium score (CACS) detected by CT has wide
implications not only for detection of CAD, but also for patient
prognosis. A recent report including 351 patients with
symptoms suggestive of CAD could demonstrate that sensi-
tivity for CAD detection by CACS alone was very high (99.2%),
whereas speciﬁcity was very low (30.3%), with an excellent
negative predictive value of 98.5%. Adding SPECT to CACS in
patients with CACS >0 yielded to increased speciﬁcity (80.9%)
with only a slight decrease of sensitivity (87.9%). The authors
stated that SPECT perfusion imaging in addition to CACS alonein patients with a CACS >0 increases the diagnostic accuracy
for detection of relevant CAD and lowers the number of
patients referred for coronary angiography [3]. On the other
hand, in asymptomatic patients without previous CAD who
have a normal SPECT CACS adds incremental prognostic
information, with a 3.6-fold relative increase for any cardiac
event (2.8-fold for death/myocardial infarction) when CACS is
high (>400) vs. minimal (≤10) [4].
Coronary CT angiography (CTA) is the most promising non-
invasive technique to depict both non-calciﬁed and calciﬁed
plaques and to estimate luminal narrowing of the coronary
arteries. Its negative predictive value is excellent in cohorts of
patients with low pre-test probability, sparing the patient
further examinations. However, if the pre-test probability is
higher, the negative predictive value of coronary CT angiogra-
phy is not that impressive [5]. A positive coronary CT
angiogram has both good diagnostic performance for detecting
and ruling out coronary stenoses >50% compared to invasive
coronary angiography at least in patients with suspected CAD
who have a low to intermediate pre-test probability of stenosis
as deﬁned by current data by Genders et al. [6]. The main
limitation of coronary CTA is in patients who have densely
calciﬁed plaques, which can cause ‘‘blooming artifacts’’,
resulting in non-interpretable images and lower diagnostic
accuracy. Moreover, patients presenting with arrhythmia/
tachycardia cannot be studied using low radiation protocols,
since diagnostic quality might be severely impaired due to
gating problems. Hence, a combination with other imaging
techniques providing information about functional parame-
ters, e.g. single photon emission tomography (SPECT), is
mandatory in patients who show stenoses by coronary CTA,
especially if these stenoses are severely calciﬁed, to increase
diagnostic accuracy [7], also see Fig. 1.
SPECT imaging studies also provide good diagnostic
accuracy for detecting signiﬁcant CAD compared to X-ray
coronary angiography [8]. Patients with a normal SPECT
perfusion have a favorable prognosis, with an annualized
event rate of 0.6% which is similar to the event risk in the
general population [9]. Conversely, patients with ischemic
regions more than ≥10% of the left ventricle (LV) may beneﬁt
from revascularization procedures [10].
As SPECT provides 3D-datasets, these can be combined
with CT images using dedicated software, permitting correc-
tion of misalignment between datasets. Combining these two
modalities in patients at higher pre-test probabilities may
increase the low speciﬁcity of coronary CTA from 63% to 95%
and the positive predictive value (PPV) from 31% to 77% [11].
Furthermore, Sato and colleagues demonstrated that of 390
arteries in 130 symptomatic patients with suspected CAD, 54
(14%) were non-evaluable by coronary CTA due to severe
calciﬁcations, motion artifacts, and/or poor opaciﬁcation. All
non-evaluable arteries by coronary CTA were considered
stenosis-positive leading to a reduced speciﬁcity and PPV.
The combination with SPECT improved speciﬁcity and PPV
Fig. 1 – A 69-year-old patient with stenotic lesions on coronary CTA but normal perfusion by SPECT: (A), (C) and (D) display
curved multiplanar CT reconstruction of the left anterior descending artery (LAD, =(A)), the left circumflex coronary artery
(RCX, =(C)), and the right coronary artery (RCA, =(D)). LAD and RCA seem to have significant stenoses (see arrows). (B) shows
an enlarged projection of the LAD perpendicular to (A) (see arrows), whereas (E) displays a three-dimensional volume
rendered reconstruction. On SPECT images (F) no perfusion abnormalities were detected (stress images first, third, fifth rows;
rest images second, fourth, and sixth rows).
Adapted from [7] with permission.
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respectively) [12]. In the subgroup of patients with chronic
kidney disease, coronary CTA has a high sensitivity (93%) for
detecting high-grade stenoses as deﬁned by quantitative
invasive coronary angiography (prevalence of high-grade
stenoses 22%). However, the downside of coronary CTA is
the low speciﬁcity of only 63% in this patient population [13].
SPECT perfusion imaging has the contrary problem: sensitivity
is rather low at only 53% but speciﬁcity is good (82%).
Combining coronary CTA with SPECT yields a sensitivity of
67% at a speciﬁcity of 86% [13].
Fusion images from coronary CTA and SPECT datasets may
provide better sensitivity than SPECT alone and even side-by-
side analysis of SPECT and coronary CTA images in patients
with multivessel disease [14]. Similar observations were made
in patients with stenoses of smaller vessels and side branches
such as diagonal branches CAD [15]. In summary, coronary
CTA/SPECT multimodality imaging reduces the number of
false positive examinations by coronary CTA alone thus
avoiding unnecessary invasive coronary angiographies and
improves the sensitivity of SPECT alone. Thus, the 2013 ESC
guidelines on the management of patients with stable
coronary artery disease [16] recommend explicitly an addi-
tional functional test in patients who have an unclear coronaryCTA examination before sending the patient to invasive
coronary angiography. In this guideline, unclear coronary
CTA examinations are deﬁned as those that have severe focal
or diffuse calciﬁcations.
Combining anatomic and functional information in
patients with suspected coronary artery disease also has
superior prognostic value. In a study comprising more than
500 patients the combination of coronary CTA and SPECT
yielded improved prediction of events (all cause death,
nonfatal infarction, unstable angina requiring revasculariza-
tion) as compared to the single modalities [17]. Patients with a
stenosis ≥50% on coronary CTA who showed a matched
perfusion defect on SPECT had the highest annualized event
rate of 9.0% (during a follow-up of almost 2 years). Patients
with normal ﬁndings by both modalities had a low annualized
event rate of 1.0% whereas those with a normal coronary CTA
but an abnormal SPECT had a higher event rate of 3.7% which
did not differ from those with an abnormal coronary CTA but a
normal SPECT (3.8%). Another recent study consisting of 324
patients [18] conﬁrmed these results using fused cardiac
hybrid images. Annual death/MI rates were 6.0, 2.8, and 1.3%
for patients with matched, unmatched, and normal ﬁndings
( p < 0.005). The same group reported that revascularization
rates within 60 days were 41, 11 and 0% for matched,
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tively ( p > 0.001) [19]. Thus, coronary CTA/SPECT multimod-
ality imaging is able to identify patients who – due to the high
event rate in patients with matched ﬁndings – are good
candidates for invasive coronary angiography and revascular-
ization [16,20].
PET/CT
In contrast to SPECT, positron emission tomography (PET)
allows quantiﬁcation of myocardial blood ﬂow (MBF) in
absolute terms. The robust attenuation correction decreases
the number of false positive ﬁndings as compared to SPECT
perfusion imaging. Furthermore, PET shows both a higher
spatial resolution and contrast resolution than SPECT [21],
resulting in improved detection of even small perfusion
deﬁcits, decreasing the number of false negative reports. A
meta-analysis reported high sensitivity (92%) and speciﬁcity
(85%) by PET for detection of CAD (≥50% diameter stenosis by
invasive coronary angiography) [22]. Coronary CTA and PET
both perform well in excluding CAD; both techniques have a
high NPV of 97% for exclusion of CAD. In contrast, both
techniques have limitations in the interpretation of a positive
result. In a study from Kajander et al. [23], n = 107 patients with
an intermediate pretest likelihood of CAD underwent multi-
modality imaging (15O-H2O PET/64 slice coronary CTA). Results
were compared to invasive angiography, including measure-
ment of fractional ﬂow reserve (FFR) when appropriate. As
expected, coronary CTA overestimated the degree of stenosis
in some patients (PPV 81%), whereas PET could not always
separate microvascular disease from epicardial stenosis (PPV
86%). However, combining these two techniques to a multi-
modality imaging approach by using information about bothFig. 2 – A 63-year-old male with positive family history who suf
depression in the stress ECG. In hybrid images (PET/CT), stress m
blue). However, coronary CT (and subsequent invasive coronary
suggesting microvascular disease as the cause of symptoms an
Adapted from [23] with permission.anatomy (CTCA) and perfusion (PET) led to an almost perfect
accuracy of 98% for detection of ≥50% diameter stenosis on a
per patient and on a per vessel analysis. The unique advantage
of such an approach is that severe microvascular disease
resulting in a diffuse reduction of myocardial blood ﬂow with
PET adenosine stress can be easily differentiated from severe
triple vessel disease by examining the coronary CTA images
(Fig. 2). On the other hand, when coronary CTA shows calciﬁed
coronary plaques, PET is able to conﬁrm or rule out
hemodynamic stenosis by presence or absence of a perfusion
defect [23].
These excellent results were conﬁrmed in a smaller study,
which compared the diagnostic accuracy of a combined
approach (coronary CTA and 15O-water PET) vs. single
approach (coronary CTA or PET, respectively) in 44 outpatients
scheduled for X-ray coronary angiography with an intermedi-
ate pretest likelihood of CAD. On a per-patient basis, the
positive predictive values (PPV) were 71% for coronary CTA,
87% for PET and 100% for PET/CTA. Similarly, on a per-vessel
basis the PPVs were 53% for coronary CTA, 53% for PET and 85%
for PET/coronary CTA. In six patients, coronary CTA analysis
was impaired by the presence of severe calciﬁcations.
However, with consideration of the PET data, all six patients
were correctly diagnosed [24].
The results of PET/coronary CTA hybrid imaging also have
important implications for patient selection for invasive
coronary angiography. This was demonstrated in a recent
study of 375 patients with suspected CAD [25]. Twenty-one
percent of patients had an unequivocal result by coronary CTA
(equivocal lesion or unable to grade stenosis severity due to
artifacts). Of these patients, 70% showed regular perfusion by
PET. Referral for invasive coronary angiography was 18% for
those with regular perfusion but 71% for those with abnormalfers from atypical angina and has 2 mm ST-segment
yocardial perfusion is diminished in most areas (green and
 angiography) reveals absence of coronary stenoses,
d ischemia in the stress ECG.
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59% of the patients with abnormal perfusion but in no one with
regular perfusion. Another 30% of patients had obstructive
CAD (stenosis ≥50%) by coronary CTA. Of these, 52% showed
abnormal myocardial perfusion imaging by PET, resulting in a
referral for invasive coronary angiography in 88% and
revascularization in 72% of the cases, respectively. Thus,
hybrid imaging with PET/coronary CTA – just as the combina-
tion of SPECT and coronary CTA – is excellent for pre-selecting
patients who might beneﬁt from invasive coronary angiogra-
phy and subsequent revascularization.
Hybrid imaging by PET/CT has also gained much attention
in the ﬁeld of chronic total occlusions (CTO). Percutaneous
coronary interventions (PCI) in these patients are still
associated with higher complication rates and higher applica-
tion of radiation and contrast media compared to patients
with non-CTO PCI [26]. Prerequisites for attempting recanali-
zation of a CTO are (1) the presence of symptoms and (2)
evidence of ischemia and myocardial viability which can be
provided by cardiac imaging [16]. Furthermore, detailed
information about the occluded vessels anatomy (e.g. by
coronary CTA) is helpful for increasing success rates of the
subsequent revascularization procedure [27,28]. CTA displays
the amount of calciﬁcation, tortuosity and actual length of the
occluded segment. Moreover, three-dimensional reconstruc-
tion of the coronary anatomy may give assistance to identify
the best angiographic projection [28]. Coronary CTA may be
useful as an add-on to ischemia/viability imaging done by
another imaging technique for predicting successful revascu-
larization in patients with CTOs.
Luo and colleagues [29] examined patients with at least 1
CTO who underwent coronary CTA and coronary angiography.
CT images and ﬂuoroscopic images were placed side by side
before or during PCI. Overall success rate was higher in this
group as compared to a group without pre-interventional
coronary CTA (87% vs. 76.4%, p = 0.016). Antegrade PCI failed
more frequently at a lesion length of >31.89 mm on coronary
CTA (odds ratio 7.04). Another recent registry [30] comprising
240 CTO lesions in 229 patients analyzed the data of pre-
procedural coronary CTA to predict time-efﬁcient successful
guidewire crossing ≤30 min. Multivariate analysis provided
several CT based morphologic adverse predictors such as
multiple occlusions, blunt stump within CTO, calciﬁcation
≥50% within CTO and bending ≥45% within CTO and two
clinical adverse predictors namely previous attempt of PCI at
CTO and occlusion duration ≥12 months or unknown. Every
predictor gets one point and the score is calculated as sum of
all points. The higher the score, the higher the risk of failed
CTO.
Thus, multimodality imaging demonstrating ischemia/
viability and morphology of the occluded vessel(s) seems
promising for identifying patients in whom an attempt of CTO
recanalization is indicated and for identifying a recanalization
strategy with the highest chance of success at minimum
procedural time.
PET/MRI
PET/MRI is a novel multimodality imaging technique which
combines the high sensitivity of PET tracers with the excellentsoft-tissue characterization by MRI. 18F-ﬂuorodeoxyglucose
(FDG) PET imaging remains the gold standard to differentiate
reversible and irreversible myocardial dysfunction [31]. Meta-
bolically active myocardial cells can be detected by increased
glucose uptake due to the up-regulation of glucose transpor-
ters in conditions of hypoxia and ischemia [32]. A drawback of
PET is that only information about perfusion and glucose
metabolism is gained rather than information about anatomy
and function. MRI is a technique, which offers detailed
information about anatomy, function and even perfusion in
a single method. While late gadolinium enhancement (LGE)
typically reveals areas of irreversible damage, such as acute
necrosis and chronic ﬁbrosis, the uptake of FDG by PET
represents a true metabolic signal of viable cells. Combining
the strengths of PET and MRI to separate non-viable tissue
from remote myocardium could be a promising approach for
identifying a maximum of viable myocardial segments in
theory, but today the role and potential of PET/MRI in ischemic
cardiomyopathy is not clearly deﬁned, and most studies rather
suggest a summative than a synergistic effect of combining
these two imaging modalities.
Nensa et al. [33] showed the feasibility of hybrid imaging
with F-18 ﬂuorodeoxyglucose (FDG) on an integrated 3-T PET/
MR imaging system. Twenty patients with acute and chronic
myocardial infarction were included. LGE images showed a
close correlation to FDG PET images with respect to myocardial
viability and infarct quantiﬁcation. Overall, 306 segments were
analyzed, 32% were diagnosed as infarcted on PET, whereas
30% of LGE images were reported as infarcted by MRI imaging.
Rischpler et al. [34] extended this information by further
studying whether additional information could be gained by
this approach. They included 28 patients with primary acute
myocardial infarction who underwent simultaneous PET/MRI
for assessment of regional FDG uptake and degree of LGE
transmurality. ‘‘PET viable’’ was deﬁned as threshold ≥50%
FDG uptake in comparison to remote myocardium, whereas
‘‘MRI viable’’ was deﬁned as LGE transmurality ≤50%. Regional
wall motion was assessed at baseline and 6 months later by
MRI. ‘‘PET viable’’ and ‘‘MRI viable’’ segments demonstrated a
lower wall motion abnormality score and a better regional wall
motion improvement after 6 months compared with ‘‘PET
non-viable’’ or ‘‘MRI non-viable’’ segments, respectively. In
discrepant ﬁndings, FDG uptake turned out to be a better
predictor for functional recovery (Fig. 3) [34].
Hence, for identiﬁcation of viability alone FDG-PET seems
to be superior to MRI. However, as MRI provides more
information than PET in terms of function and anatomy it
should remain the ﬁrst line technique to evaluate viability. PET
should be employed in those patients where identiﬁcation of
additional regions of viability would turn a clinical decision
more toward revascularization.
Does every patient need multimodality imaging?
In most patients who are referred for work-up of suspected or
known CAD by non-invasive cardiac imaging, one single
imaging technique is often sufﬁcient. MRI in particular is able
to provide information about morphology, myocardial func-
tion and perfusion in a single ‘‘one-stop-shop’’ technique.
Fig. 3 – Images illustrating different combinations of FDG uptake (PET) and LGE transmurality (MRI). Left column: FDG ≥50%/
LGE non-transmural (‘‘PET viable/MRI viable’’); middle column: FDG <50%/LGE transmural (‘‘PET non-viable/MRI non-viable’’);
right column: FDG <50%/LGE non-transmural (‘‘PET non-viable/MRI viable’’). White arrows indicate areas of scar (LGE), and
areas of ischemia (reduced tracer uptake), respectively.
Adapted from [34] with permission.
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ques (CT, SPECT, PET) are associated with some radiation
exposure. Furthermore, one has to keep in mind that
additional imaging will result in higher costs. Nevertheless,
there are some conditions which may justify a multimodality
imaging approach: (1) Patients with intermediate pretest
likelihood for CAD, in whom the initial imaging test (often
coronary CTA) gives an inconclusive result, additional ische-
mia imaging is a guideline-supported option for obtaining a
deﬁnite diagnosis [16]. (2) Chronic total occlusions (CTO).
Beside the evidence of ischemia associated by an occluded
vessel, detailed anatomical information about the occluded
vessel is helpful prior to revascularization attempts [35].
Simultaneous acquisition of coronary CTA and stress
nuclear perfusion techniques (SPECT; PET) as a hybrid
approach in patients with suspected CAD poses difﬁcult
questions regarding the use of beta-blockers. They are often
requested for coronary CTA to lower heart rate yielding better
diagnostic images, whereas use of beta-blockers could reduce
the sensitivity of perfusion imaging. Furthermore, routinely
combining two imaging techniques using dedicated hybrid
machines, which are based on radiation exposure, will
inevitably increase the radiation dose, even though recenttechnical progress has resulted in lower radiation doses both
for coronary CTA and for SPECT. Moreover, some of the
imaging techniques are still not widely available yet (e.g. PET),
restricting its use to highly specialized medical centers.
Further technological improvements of each imaging tech-
nique (e.g. higher resolution, lower radiation) and ongoing
development of dedicated image fusion software might
facilitate a more widespread clinical use of multimodality
imaging in the clinical setting. Future guidelines should
include recommendations for the use of multimodality
imaging assisting the clinician in choosing the right combina-
tion of imaging modalities for the right patient.
Conclusion
In summary, a multimodality imaging approach is able to
provide detailed information about patients with suspected or
known CAD in terms of anatomy (plaques, stenosis) and
function (perfusion, metabolism). This is of importance, since
there is a variable relationship between the anatomic degree of
a stenosis and the occurrence of myocardial ischemia. Results
will inﬂuence diagnosis, risk stratiﬁcation, potential treatment
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 6 2 – e 4 6 9e468strategies and even prognosis of the patients. However, major
drawbacks of multimodality (hybrid) imaging are increased
radiation exposure and higher costs in comparison to a single
imaging approach. Further prospective multicenter studies are
needed to clarify the future role of its clinical utility, including
data about prognosis and cost-effectiveness.
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